Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
08/11/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Abstract Acceptance for Podium Presentation at Plastic Surgery: The Meeting 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/10/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Abstract Acceptance for Podium Presentation at the ANESTHESIOLOGY® 2022 Annual MeetingNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/04/20229:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/28/20224:50PMPR Newswire (US)AcelRx to Host Second Quarter 2022 Financial Results Call and Webcast on August 11, 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/28/20224:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/18/20224:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/15/20227:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/15/20227:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/15/20227:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/15/20227:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/15/20227:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/15/20227:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/15/20227:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/08/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/03/20226:06AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/03/20226:06AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/02/20225:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/20/202212:49PMPR Newswire (US)AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/19/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Provides Update on Reduced FDA REMS Requirements Related to DSUVIA®NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/16/20229:17AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/16/20227:30AMPR Newswire (US)AcelRx Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/10/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Publication of Results from an Investigator-Initiated Trial on Sufentanil Sublingual Tablet (SST) Compared to Standard Intravenous Opioids during Plastic Surgery Procedures Performed under General AnesthesiaNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/09/20227:30PMPR Newswire (US)AcelRx to Host First Quarter 2022 Financial Results Call and Webcast on May 16, 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/09/20225:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/03/20225:24PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/25/20228:30AMPR Newswire (US)Minimal Side Effects and Short Recovery Time Reported for DSUVIA®-Treated Patients: Plastic Surgery Podium Presentation at The Aesthetic Meeting 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/22/20226:04AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/21/20228:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Upcoming Podium Presentation on Use of DSUVIA® for Plastic Surgery Procedures at The Aesthetic Meeting 2022NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/20/20225:15PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/31/20224:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX

Your Recent History

Delayed Upgrade Clock